Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

RFA-DK-25-008: Diabetes Research Centers (P30 Clinical Trial Optional)

Closed Closed June 18, 2024 Opportunity RFA-DK-25-008

This grant is closed. A newer notice from the same program is open now: Diabetes Research Centers (P30 Clinical Trial Optional) (RFA-DK-26-310). Status: Closes January 27, 2027 (81 days left). It is in our archive of National Institutes of Health notices from 2024.

National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on June 18, 2024.

From the official notice on Grants.gov, last changed March 29, 2024. Checked November 7, 2026.

About this NIH notice

Projects funded under RFA-DK-25-008 were run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, 6 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.

Application due dates, page limits and budget limits are set in the notice. Read RFA-DK-25-008 in the NIH Guide.

Other notices with this title

National Institutes of Health has posted this title under other numbers: earlier or later rounds, or the same competition for another area. Each has its own dates and may change its rules.

NoticePostedDeadlineStatus
RFA-DK-26-310December 5, 2025Closes January 27, 2027 (81 days left)Open
RFA-DK-21-029October 13, 2021Closed March 8, 2022Closed

Key dates

PostedMarch 29, 2024
DeadlineJune 18, 2024
Archived by Grants.govJuly 24, 2024

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

All 15 applicant types the notice lists

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

What the grant funds

This Notice of Funding Opportunity (NOFO) invites applications for Diabetes Research Centers (DRCs) that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. The purpose of this Centers program is to bring together basic and clinical investigators to enhance communication, multidisciplinary collaboration, and effectiveness of ongoing research in Diabetes Research Center topic areas. By providing shared access to specialized technical resources (research cores) and supporting a Pilot and Feasibility Program (P and F), DRCs are intended to create an environment that provides the capability for accomplishments greater than those that would be possible by individual research project grant support alone. New Center programs that bring in diverse perspectives, propose unique scientific themes, or provide innovative resources are encouraged. Emphasis will be placed on Center programs that propose enhanced synergies with other NIDDK-funded programs as well as providing a rich mentoring environment for future diabetes researchers. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

Category: Food and Nutrition, Health.

Funded under RFA-DK-25-008 so far

NIH funded 6 projects under RFA-DK-25-008 in fiscal 2025 to 2026, at 6 institutions. The median yearly award was $344,159.

Recently funded projects
ProjectInstitutionFiscal yearAward
Core A: Islet Production P30University of California, San Francisco2026$231,265
NYR-Diabetes Research Center (NYR-DRC) P30Albert Einstein College of Medicine2026$224,130
Pilot & Feasibility Program P30Indiana University Indianapolis2026$445,447
University of Colorado Anschutz Medical Campus DRC P30University of Colorado Denver2026$1.3 million
Diabetes Research Center (DRC) P30University of California, San Diego2026$1.7 million
Administrative Core P30Wake Forest University Health Sciences2026$558,133

From NIH RePORTER, which lists each project once per fiscal year it was funded. Amounts are the yearly award.

Who has won Diabetes, Digestive, and Kidney Diseases Extramural Research grants before

From fiscal 2021 to 2025, Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $9.6 billion across 7,877 grant awards, an average of $1.2 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
Regents of the University of MichiganMichigan273$345 million
The Trustees of the University of PennsylvaniaPennsylvania187$272 million
University of Pittsburgh - of the Commonwealth System of Higher EducationPennsylvania209$238 million
The Washington UniversityMissouri187$227 million
The Regents of the University of California, San FranciscoCalifornia176$208 million

Top states: California ($1.2 billion), Massachusetts ($932 million), New York ($798 million), Pennsylvania ($762 million), Texas ($482 million).

Applying now

This notice no longer takes applications. Apply under the newer notice, RFA-DK-26-310, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is RFA-DK-25-008 still open?

No. It closed on June 18, 2024. A newer notice is open: RFA-DK-26-310, closes January 27, 2027 (81 days left).

Who can apply for Diabetes Research Centers (P30 Clinical Trial Optional)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for Diabetes Research Centers (P30 Clinical Trial Optional)?

Closed June 18, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

Who has been funded under RFA-DK-25-008?

NIH RePORTER lists 6 projects funded under RFA-DK-25-008 in fiscal 2025 to 2026, at 6 institutions. The most were at University of California, San Francisco, Albert Einstein College of Medicine, Indiana University Indianapolis.

Who has won Diabetes, Digestive, and Kidney Diseases Extramural Research grants before?

The largest recipients over five fiscal years were Regents of the University of Michigan, The Trustees of the University of Pennsylvania, University of Pittsburgh - of the Commonwealth System of Higher Education. The program made 7,877 awards worth $9.6 billion in that time.

Similar open grants